Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial

Table 5

The result for safety analysis.

Variable	Period	SJDBT group		Placebo group		p
		Mean ± SD	()	Mean ± SD	()
SBP, mmHg	0 weeks					0.275
	2 weeks		0.471		0.445	0.674
	4 weeks		0.397		0.893	0.431
DBP, mmHg	0 weeks					0.168
	2 weeks		0.140		0.038	0.321
	4 weeks		0.047		0.922	0.829
Pulse, bpm	0 weeks					0.929
	2 weeks		0.477		0.216	0.898
	4 weeks		0.128		0.460	0.090
AST, IU/L	0 weeks					0.842
	4 weeks		0.157		0.217	0.638
ALT, IU/L	0 weeks					0.256
	4 weeks		0.210		0.609	0.587
BUN, mg/dL	0 weeks					0.149
	4 weeks		0.138		0.489	0.953
Cre, mg/dL	0 weeks					0.242
	4 weeks		0.513		0.779	0.320

SBP: systolic blood pressure; DBP: diastolic blood pressure; AST: aspartate aminotransferase; ALT: alanine transferase; BUN: blood urea nitrogen; Cre: creatinine; () represents value of comparison between 0 weeks and weeks within each group; represents value of comparison between SJDBT group and placebo group in each period.